AI company analysis
Most AI answers about a stock come from memory. EquityLK AI reads the company's actual financials, prices, filings and news first, so every report is built on this company's latest numbers, not on stocks in general. Pick a stock and generate a report.
Ask the market
Ask any question about Sri Lanka's stock market, screening ideas, sector comparisons, long-term candidates. If you keep a portfolio here, you can ask about your own holdings too, whether you are diversified or what is carrying the risk. We pick the right data for your question, then write you a private report.
Latest reports
48 publishedEvidence points bullish: September profit more than doubled on stronger revenue and margins. The catch is debt stood at 101.5% of owners' equity.
Evidence points to a weaker company than the share’s book premium suggests: revenue fell 32.4% and the operating loss widened. The catch is a LKR 117 million September net profit, generated below the operating line.
Evidence points bullish: annual profit growth and a net-cash balance sheet support a moderately undervalued price. The latest quarter's profit slipped despite higher sales.
Evidence points bearish: the September loss reached LKR 1.5 billion and equity is negative. The counterpoint is planned LPG supply restoration, subject to regulatory approvals.
Evidence points bullish because September-quarter revenue and profit grew 37.4% and 42.4% with wider margins. Rising debt is the main counterweight.
Evidence is balanced: September revenue grew 32.0%, while the shares sit near their most expensive year-end valuation record. The catch is that gross margin was the weakest September result on record.
Evidence points bearish because the September quarter swung to a LKR 101 million loss, outweighing the capital raise. The counterpoint is a LKR 1.0 billion rights issue that strengthens Tier 1 capital.
Evidence points bearish because September profit fell 58.9% despite higher sales, exposing a sharp margin squeeze. The counterweight is an Undervalued score of 80.
Evidence points bearish: debt equals 205% of owners' equity while losses persist. The counterweight is a 0.55 times P/B.
Evidence points bullish because September revenue grew 16.1% while margins ranked near the company’s best. The catch is a 4.02 times book valuation.
Evidence points bullish: CDC scores 91 of 100 for value across the CSE and has substantial short-term asset cover. The contrary is that September net profit fell 11.5% year-on-year.
Evidence points bullish: reported nine-month profit rose 34% and NTB falls in the CSE's undervalued band. The catch is that September-quarter profit fell 27.8% despite revenue growth.
Evidence points bearish because the share trades at 2.49 times book despite unresolved reporting and business-model questions. The September quarter produced LKR 21.6 million profit.
Evidence points bullish because HNB scores 99/100 on exchange-wide valuation while lending and net interest income expanded strongly. The counterweight is September-quarter profit fell 4.9% as margins tightened.
Evidence points bullish because September profit rose 28.6% on stronger sales, against a moderately undervalued valuation. The catch is a 6.1-point gross-margin contraction.
The evidence points bearish because September-quarter profit fell 98.1% and the margin collapsed. The counterweight is a moderately undervalued market-wide score of 63.
Evidence points bearish because September's LKR 1.5 billion loss and negative equity leave no earnings or asset base behind the price. The offset is three LPG shipments arranged, subject to regulatory approval.
Evidence points bearish: trailing operations remain loss-making and the shares trade at 435 times book value. The September quarter returned to profit.
Evidence points bearish because Office Equipment remains loss-making while the shares trade at 20.2 times book value. The September loss narrowed by LKR 1.3 million.
Evidence points bearish because September revenue fell 51.2% and operations moved into loss at a demanding valuation. The catch is a substantial net cash position.
The evidence points bearish: the group moved from profit to a first-half loss while trading at 13.7 times audited earnings. The offset is an agreed insurer acquisition with LKR 10.7 billion of premiums.
Evidence points bearish: 5.0 times book value accompanies a 21.1% September revenue decline. The counterpoint is the reported FY2025-26 return to profit.
Evidence points bullish because September operating profit rose 56.5% as margins widened, reinforcing a moderately undervalued starting point. The catch is debt equal to 116.8% of owners' equity.
Evidence points bearish because the latest quarterly loss widened and trading was halted pending accounts. The counterweight is an 11.8% trailing return on equity.
Evidence points bullish: September profit rose 62.4% as operating margin reached its best recorded September level. The counterweight is a P/B near its historical peak.
Evidence points bullish as first-half attributable profit rose 98% and investment is expanding higher-value carbon capacity. The catch is debt reached 62.1% of owners' equity at the last audited year-end.
Evidence points bullish: September-quarter profit rose 66.3% as margins widened. The catch is debt equals 255.8% of owners' equity.
Evidence is balanced: TILE trades at 0.66 times book value, but September operating profit weakened sharply with sales. The value case is challenged by quarterly net profit falling 41.9%.
Evidence points bearish because the price asks 122 rupees for each rupee of trailing profit despite weak return on equity. The counterpoint is that June delivered the company’s strongest comparable margins.
Evidence points bearish: September profit fell 22.5% despite revenue growth, showing that the recent expansion is converting less effectively into earnings. The counterweight is a 7.1 times P/E, among manufacturing's cheapest.
Evidence points bullish: sales and profit continued to grow while LMF trades cheaply against sector book value. The catch is that its P/B is more expensive than 90% of days since 2012.
Evidence points bullish: nine-month profit rose 15% and the shares sit in the CSE's cheapest fifth. The catch is a weaker operating margin.
Evidence points bullish because JFP's 5.7% yield is unusually high for manufacturing peers and the latest quarter remained profitable. The catch is that margins fell from the prior quarter while debt is substantial.
Evidence points bullish: the shares score 93 of 100 for value and September operating profit rose 23.9%. The catch is net profit slipped 0.7% as costs below operations increased.
Evidence points bullish: revenue rose 26.5% while VONE trades at 0.84 times book, leaving a profitable diversified group cheaply valued. The catch is September operating margin was the weakest of eight comparable September quarters.
Evidence points bearish because the shares trade at 79.5 times earnings, far above insurance peers. Audited return on equity of 35.7% is the main counterweight.
The evidence points positive because debt has roughly halved while the shares screen moderately undervalued. The catch is that September profit fell 46.2% year-on-year as margins compressed.
Evidence points bullish because revenue grew 17.1% while operating profit increased and the last annual balance sheet was lightly geared. The catch is September net profit fell as margins compressed and finance costs rose.
Evidence points to a weaker company: September turned to a LKR 2.4 million loss and an auditor disclaimer put it on the Watch List. The counterweight is a 5.62 times P/E.
Evidence points to a stronger lender but not a clear valuation case: September operating margin was its best in five comparable quarters. The catch is a P/B in the sector’s 79th percentile and no dividend.
Evidence points bearish: a LKR 1.27 billion first-half loss has replaced profit and the shares sit in the exchange's overvalued fifth. FY2026 profit of LKR 2.1 billion is the main counterpoint.
Evidence points to a weaker insurer despite an undervalued score: September profit fell 98.1% as margin collapsed. The counterweight is its 84/100 market-wide value score.
Evidence points bearish because the group is loss-making and scores 18/100 on market-wide valuation. The counterweight is a LKR 5.1 billion general-insurance acquisition, subject to approval.
Evidence points to a stronger lender: audited profit more than doubled and book value increased, while the shares screen undervalued. The catch is liabilities rose to 4.01 times equity.
Evidence points to a stronger business than the valuation suggests: September revenue grew 27.9% and profit rose despite lower operating earnings. The catch is operating margin fell to 9.2%, among its weakest September readings.
Evidence points bullish because September delivered the bank's best comparable operating and net margins, reinforcing an Undervalued score of 97. The counterweight is a reported decline in net interest margin.
The evidence points bearish: the twelve months to September remained loss-making despite a Q2 recovery, so current profitability is not yet established. The counterpoint is a 0.72 P/B, cheaper than 85% of its own history.
Evidence points bearish: operations lost LKR 287 million while GHLL sits in the market's overvalued fifth. The catch is a LKR 117 million quarterly profit.
Every report is built from EquityLK's own market data. AI research can contain errors, so treat it as a starting point. It is not investment advice or a recommendation to buy or sell any security.